Cancer Issues Research Articles in Vol. 127, No. 24
December 07, 2021
December 07, 2021
ATLANTA, Georgia, Dec. 7 -- Cancer, a peer-reviewed journal from the American Cancer Society that says it features cancer research, risk reduction, treatment and patient care, published research articles, including the following topics, in its Vol. 127, No. 24 edition:
Original Articles:
* Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events . . .
Original Articles:
* Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events . . .